(Q43447818)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12548595%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

title

Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12548595%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12548595%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

author name string

Gary M Clark

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12548595%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

D Craig Allred

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12548595%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Syed Mohsin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12548595%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Gary Chamness

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12548595%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Richard M Elledge

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12548595%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

language of work or name

English

0 references

publication date

1 February 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12548595%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12548595%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

volume

97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12548595%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12548595%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

page(s)

545-553

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12548595%20AND%20SRC:MED&resulttype=core&format=json

Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer

17 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11083

7 January 2021

Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11083

7 January 2021

Steroid-hormone receptors and survival after first relapse in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11083

7 January 2021

Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11083

7 January 2021

Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11083

7 January 2021

bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11083

7 January 2021

Prognostic value of bcl-2 expression in invasive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11083

7 January 2021

Prognostic and predictive value of p53 and p21 in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11083

7 January 2021

Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11083

7 January 2021

Worsening bone scan in the evaluation of antitumor response during hormonal therapy of breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11083

7 January 2021

Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11083

7 January 2021

neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11083

7 January 2021

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11083

7 January 2021

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11083

7 January 2021

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11083

7 January 2021

Predictive value of c-erbB-2, p53, cathepsin-D and histology of the primary tumour in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11083

7 January 2021

Predicting Response to Endocrine Therapy in Human Breast Cancer: A Hypothesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11083

7 January 2021

Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11083

7 January 2021

The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11083

7 January 2021

bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11083

7 January 2021

Proliferative activity, histological grade and benefit from adjuvant chemotherapy in node positive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11083

7 January 2021

Influence of S-phase fraction on metastatic pattern and post-recurrence survival in a randomized mammography screening trial.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11083

7 January 2021

Identifiers

DOI

10.1002/CNCR.11083

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12548595%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12548595%20AND%20SRC:MED&resulttype=core&format=json